[Cutaneous forms of lupus].
Moureaux
P
P
D000974:Antibodies, Antinuclear / Q000276:immunology; D001324:Autoantigens / Q000276:immunology; D001327:Autoimmune Diseases / Q000139:chemically induced / Q000151:congenital / Q000473:pathology*; D002908:Chronic Disease; D003875:Drug Eruptions / Q000276:immunology / Q000473:pathology; D005260:Female; D006801:Humans; D007159:Immunologic Tests; D007231:Infant, Newborn; D016682:Lupus Coagulation Inhibitor / Q000032:analysis / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced / Q000150:complications* / Q000151:congenital / Q000473:pathology; D008297:Male; D011247:Pregnancy; D011248:Pregnancy Complications / Q000276:immunology; D011256:Pregnancy Outcome; D020733:RNA, Small Cytoplasmic; D012261:Ribonucleoproteins / Q000276:immunology; D012871:Skin Diseases / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology; D000099207:SS-A Antigen
D000974:Antibodies, Antinuclear; D001324:Autoantigens; D016682:Lupus Coagulation Inhibitor; D020733:RNA, Small Cytoplasmic; D012261:Ribonucleoproteins; D000099207:SS-A Antigen; C116006:RO60 protein, human
Les formes cutanées du lupus.